[ad_1] Novo Nordisk’s U.S.-listed stock jumped rose 13% early Tuesday, after the company said its…
Tag:
Novo Nordisk A/S Series B
-
-
STOCK MARKET
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
by userby user[ad_1] Morgan Stanley on Friday lifted its forecast for annual sales of weight-loss drugs to…
-
STOCK MARKET
Hit Wegovy weight-loss drug on track for $4 billion in U.S. sales despite supply constraints, analyst says
by userby user[ad_1] The hit Wegovy weight-loss drug is on track for sales of over $4 billion…
-
STOCK MARKET
Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval
by userby user[ad_1] Back around 2005, in a pharmaceutical research lab in Nutley, N.J., Becky Taub noticed…
-
STOCK MARKET
Lilly’s new diabetes drug doubled sales expectations. It may also be used to treat obesity
by userby user[ad_1] Eli Lilly & Co. Inc.’s LLY, -2.63% steady transformation into a developer of both…
-
STOCK MARKET
‘There’s no way that patients are going to be able to afford that.’ Why aren’t new drugs that can help you lose weight more widely used?
by userby user[ad_1] A pair of new drugs offer something many Americans desperately want: a way to…
-
STOCK MARKET
Lilly’s experimental weight-loss drug may be a ‘multibillion-dollar opportunity’
by userby user[ad_1] Eli Lilly & Co. Inc.’s LLY, -1.46% promising new weight-loss drug is taking aim…